Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process. Lori A. Leslie, MD: Hello, and welcome to CURE Expert Connections® ...

Acalabrutinib plus obinutuzumab shows superior long-term outcomes in treatment-naive chronic lymphocytic leukemia.

Chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL) are types of blood cancer. They develop in types of white blood cells called B cells or T cells, or the precursors to these cells.

Experts recently set out to determine whether distinct subpopulations of clonal cells with different proliferative potential exist within the same individual with CLL. The study used deuterium-labeled ...

Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...

CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023. In honor of September being blood cancer awareness month, we took a look at five noteworthy ...

A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track ...